Brokerages Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) PT at $39.89Zolmax • about 1 month agoShares of Kymera Therapeutics, Inc. (NASDAQ:KYMR - Get Free Report) have received a consensus rating of "Moderate Buy" from the twelve analysts that are presently covering the company, MarketBeat...